However, these cells do not express VEGFR1, an observation in agreement with another report.20 This lack of receptor expression, therefore, precludes a VEGF-VEGFR1 mechanism that could be disrupted by SPARC in the tumor cells. Here, FLT1 is linked to neoplasm.